SANA241220P10000
- 0.00
- 0.000.00%
Sana Biotechnology Newsroom
H.C. Wainwright Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $8
Sana Biotechnology Analyst Ratings
JMP Securities Maintains Sana Biotechnology(SANA.US) With Hold Rating
TD Cowen Maintains Sana Biotechnology(SANA.US) With Hold Rating
H.C. Wainwright Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $8
Sana Biotechnology's Strategic Shift to Autoimmune Diseases Drives Buy Rating Despite Lowered Price Target
Citi Maintains Sana Biotechnology(SANA.US) With Buy Rating, Maintains Target Price $15
BofA Securities Initiates Sana Biotechnology(SANA.US) With Buy Rating
Sana Biotechnology Cut to Market Perform From Market Outperform by JMP Securities
Sana Biotechnology Analyst Ratings
H.C. Wainwright Maintains Sana Biotechnology(SANA.US) With Buy Rating, Cuts Target Price to $8
Analysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Integra Lifesciences (IART)
JMP Securities Downgrades Sana Biotechnology(SANA.US) to Hold Rating
J.P. Morgan Sticks to Their Hold Rating for Sana Biotechnology (SANA)
Morgan Stanley Initiates Sana Biotechnology(SANA.US) With Buy Rating, Announces Target Price $12
Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Sana Biotechnology (SANA)
Sana Biotechnology: Strong Buy Rating Amidst Promising Pipeline and Solid Financials
Sana Biotechnology Price Target Raised to $15.00/Share From $8.00 by Citigroup
Sana Biotechnology Analyst Ratings
HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $11